| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.004 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.005 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.12 | 0.005 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.005 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.005 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.005 |